Overview

Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis

Status:
Completed
Trial end date:
2019-05-16
Target enrollment:
Participant gender:
Summary
International clinical trial to compare ponesimod and teriflunomide in relapsing multiple sclerosis
Phase:
Phase 3
Details
Lead Sponsor:
Actelion
Treatments:
Ponesimod
Teriflunomide